JAMA Network
About The Study: The combination of exercise and glucagon-like peptide-1 receptor agonist (GLP-1RA) (liraglutide) was the most effective weight loss strategy while preserving bone health in this randomized clinical trial. Liraglutide treatment alone reduced bone mineral density at clinically relevant sites more than exercise alone despite similar weight loss.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
